You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unresectable Urinary Neoplasms

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Bladder Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)

Completed
  • Urinary Bladder Neoplasms
  • Irreversible electroporation (IRE)
  • NanoKnife
  • Guangzhou, Guangdong, China
    Biological treatment center in Fuda cancer hospital
Sep 1, 2021

RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY

Recruiting
  • Bile Duct Neoplasms
  • Gall Bladder Carcinoma
  • Radio frequency ablation
  • Hyderabad, Telangana, India
    Asian Institute of Gastroenterology
Apr 1, 2022

Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of

Not yet recruiting
  • Bladder Cancer
  • +3 more
  • Geriatric-8 Survey
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

Recruiting
  • Advanced Bladder Urothelial Carcinoma
  • +23 more
  • Riverside, California
  • +8 more
Jul 16, 2022

Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,

Not yet recruiting
  • Bladder Squamous Cell Carcinoma
  • +10 more
  • Biospecimen Collection
  • +5 more
  • Atlanta, Georgia
  • +3 more
Feb 20, 2023

Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus

Active, not recruiting
  • Adult Solid Neoplasm
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Urinary Bladder Tumors Trial in Worldwide (Durvalumab, Olaparib, Placebo)

Active, not recruiting
Has Results
  • Urinary Bladder Neoplasms
  • Birmingham, Alabama
  • +44 more
Dec 21, 2022

Bladder Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v8, Stage IVA Bladder Cancer AJCC v8 Trial in Los Angeles

Active, not recruiting
  • Bladder Urothelial Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Dec 2, 2021

Bladder Cancer, Urethral Cancer, Urachal Cancer Trial in Houston (5-Fluorouracil (5-FU), Leucovorin, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • 5-Fluorouracil (5-FU)
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 18, 2021

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Unresectable Pancreatic Cancer, Unresectable Bile Duct Carcinoma, Unresectable Biliary Tract Carcinoma Trial (Tripegfilgrastim)

Not yet recruiting
  • Unresectable Pancreatic Cancer
  • +2 more
  • (no location specified)
Nov 13, 2023

Colon Cancer Liver Metastases Trial (sequential adult left lateral lobe liver transplantation (SALT))

Not yet recruiting
  • Colon Cancer Liver Metastases
  • sequential adult left lateral lobe liver transplantation (SALT)
  • (no location specified)
Oct 3, 2023

Unresectable or Metastatic Colorectal Cancer Trial in Shenyang (FOLFOX/FOLFIRI)

Recruiting
  • Unresectable or Metastatic Colorectal Cancer
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Mar 22, 2023

Unresectable/Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib plus camrelizumab and capecitabine)

Recruiting
  • Unresectable/Metastatic Colorectal Cancer
  • Fruquintinib plus camrelizumab and capecitabine
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 19, 2023

Secondary Malignant Tumor of Retroperitoneum, Secondary Malignant Tumor of Peritoneum, Pseudomyxoma Peritonei Trial in Cleveland

Not yet recruiting
  • Secondary Malignant Neoplasm of Retroperitoneum
  • +2 more
  • Intestinal, Multivisceral or Modified Multivisceral Transplantation
  • +3 more
  • Cleveland, Ohio
    Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), C
Oct 10, 2023

SpectrosCopy: Diagnostic Aid in oncologY - Application to

Recruiting
  • Urinary Bladder Tumour
  • Urine vibrational analysis
  • Reims, France
    Damien JOLLY
Oct 11, 2023

Pancreatic Tumors Trial in Shanghai (Utidelone injection in combination with gemcitabine)

Recruiting
  • Pancreatic Neoplasms
  • Utidelone injection in combination with gemcitabine
  • Shanghai, Shanghai, China
    Shanghai First People's Hospital
Mar 21, 2023

Patterns of Urinary Bladder Cancer in Darfur, Suda

Completed
  • Urinary Bladder Cancer
    • Darfur, Sudan
      Nyala specialized hospital
    Nov 27, 2023

    Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as

    Completed
    • Colorectal Cancer Metastatic
    • Targeted agent
    • (no location specified)
    Aug 31, 2023

    Unresectable Colorectal Liver Metastases Trial in Nanjing (Selective internal radiation therapy (SIRT) with yttrium-90 carbon

    Recruiting
    • Unresectable Colorectal Liver Metastases
    • Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres
    • Nanjing, Jiangsu, China
      Zhongda Hospital Southeast University
    Jan 26, 2023

    Unresectable Pancreatic Cancer Trial (creon 35.000 Ph.U (R), Best Standarard of Care)

    Not yet recruiting
    • Unresectable Pancreatic Cancer
    • creon 35.000 Ph.U (R)
    • Best Standarard of Care
    • (no location specified)
    Oct 19, 2023

    Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

    Completed
    • Urinary Bladder Cancer
    • +4 more
    • Neutrophil to lymphocyte ratio
    • Cairo, Egypt
      Ain Shams university
    Jul 15, 2023

    HepaSphere Transarterial Chemoembolization Combined With Hepatic

    Not yet recruiting
    • Colorectal Liver Metastases (CRCLM)
    • DEB-TACE plus HAIC
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    May 25, 2023

    Unresectable Gallbladder Cancer Trial in Guangzhou (Carrilizumab plus GEMOX)

    Not yet recruiting
    • Unresectable Gallbladder Cancer
    • Carrilizumab plus GEMOX
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Jun 16, 2023